(Q39797855)

14 September 2017

1 reference

title

Low-dose heparin: is the risk worth the benefit? (English)

1 reference

Cardiology and cardiovascular medicine

14 September 2017

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

27 June 2022

author name string

S. Wessler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A377931

27 June 2022

S. N. Gitel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A377931

27 June 2022

language of work or name

English

0 references

publication date

1 July 1979

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:0002870379903259?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

https://api.elsevier.com/content/article/PII:0002870379903259?httpAccept=text/plain

27 June 2022

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

27 June 2022

published in

American Heart Journal

1 reference

14 September 2017

volume

98

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

94-101

1 reference

Deep venous thrombosis and pulmonary embolism: prediction, prevention and treatment

14 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

12 April 2023

PULMONARY EMBOLISM

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

The spectrum of pulmonary embolism: twenty years later

12 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Low-Dose Heparin Prophylaxis for Postoperative Venous Thromboembolism

12 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Anticoagulant therapy in surgery

12 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Results in the prophylaxis of postoperative thromboembolism

12 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Effects of vitamin B12, B6 and procaine on the conditioned escape response.

12 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

12 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER.

12 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Relationship between Factor V and Activated Factor X in the Generation of Prothrombinase

12 April 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Investigation of the apparent thrombogenicity of thrombin

12 April 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Heparin-accelerated inhibition of activated factor X by its natural plasma inhibitor

12 April 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Chemistry of the hemostatic mechanism and its relationship to the action of heparin

12 April 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

In vitro and in vivo correlation of clotting protease activity: Effect of heparin

12 April 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

The nature of heparin antithrombin action

12 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial

12 April 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Low-dose heparin prophylaxis against fatal pulmonary embolism

12 April 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Low dose heparin: bleeding and wound complications in the surgical patient. A prospective randomized study

12 April 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Leg-vein thrombosis following myocardial infarction

12 April 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Frequency of venous thrombosis after myocardial infarction

12 April 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Myocardial Infarction and Deep-vein Thrombosis

12 April 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Heparin in the Prevention of Deep Vein Thrombosis after Myocardial Infarction

12 April 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Low-dose heparin after myocardial infarction.

12 April 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis

12 April 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction

12 April 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Venous thromboses in myocardial infarction. Comparison in heparin dosage

12 April 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Deep venous thrombosis after myocardial infarction. Predisposing factors

12 April 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Preventing thromboembolism after myocardial infarction: effect of low-dose heparin or smoking

12 April 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Heparin and ventricular arrhythmias after myocardial infarction

12 April 2023

49

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Prevention of fatal postoperative thromboembolism by heparin prophylaxis

12 April 2023

51

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Medical Histories and Reflections

12 April 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

The use of plasma 125I fibrinogen levels for the detection of deep venous thrombosis in geriatric patients

12 April 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors

12 April 2023

55

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke

12 April 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Safety of mini-dose heparin administration for neurosurgical patients

12 April 2023

57

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Investigation of relation between use of oral contraceptives and thromboembolic disease

12 April 2023

59

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Thromboembolism and oral contraceptives: an epidemiologic case-control study

12 April 2023

60

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Investigation of Relation between Use of Oral Contraceptives and Thromboembolic Disease. A Further Report

12 April 2023

61

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Oral Contraception and Increased Risk of Cerebral Ischemia or Thrombosis

12 April 2023

62

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Oral contraceptives and stroke in young women. Associated risk factors

12 April 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Puerperal thromboembolism and suppression of lactation

12 April 2023

64

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Diethylstilbestrol: Recommended Dosages for Different Categories of Breast Cancer Patients

12 April 2023

67

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo

12 April 2023

69

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

12 April 2023

70

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Postoperative Thromboembolism and the Use of Oral Contraceptives

12 April 2023

71

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Oral contraceptive use in patients with thromboembolism following surgery, trauma, or infection

12 April 2023

72

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Association Between Oral Contraceptives and Myocardial Infarction

12 April 2023

73

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis

12 April 2023

76

1 reference

https://api.crossref.org/works/10.1016/0002-8703(79)90325-9

12 April 2023

Identifiers

1 reference

14 September 2017

1 reference